Fumarylacetoacetate Hydrolase (FAH) Antibody,Abbexa,abx026534
This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT).
Host
Rabbit
Reactivity
Human
Application
ELISA, WB, IHC, IF/ICC
Conjugate
Unconjugated
Platform ID
BAB080021326
Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameFumarylacetoacetate Hydrolase (FAH) Antibody
Cat. No.abx026534
Accession NumberP16930
HostRabbit
IsotypeIgG
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, WB, IHC, IF/ICC
Working DilutionsWB: 1/1000, IHC-P: 1/50 - 1/100, IF/ICC: 1/10 - 1/50. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
Molecular WeightCalculated MW: 46.4 kDa
TargetFAH
ImmunogenKLH-conjugated synthetic peptide between 7-33 amino acids from the N-terminal region of human FAH.
PurityPurified through a protein A column, followed by peptide affinity purification.
Appearance/FormLiquid
FormulationPBS containing 0.09% sodium azide.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Polyclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.